Bowel Stimulators Market size is anticipated to witness more than 6.5% CAGR during the forecast period i.e., between 2024-2036. Bowel stimulator is a nerve stimulator that is surgically implanted to help a patient reduce the number of bowel accidents caused by fecal incontinence. The growth of the market can be attributed to the increasing prevalence of bowel incontinence, in which the patient is unable to control bowel movement. Furthermore, the rising demand for quick, and long-term treatment plans amongst adults, is estimated to fuel the market growth. Along with this, growing adoption of surgeries, favorable medical reimbursement policies, and higher disposable income are some of the common factors estimated to boost the market growth.
Moreover, this disorder is more common amongst the older population, as aging results in loss of control over muscles. As a result, the rising geriatric population across the globe is estimated to boost the market growth. As per the data by the World Bank census, 9.321% of the total population was aged above 65 years, in 2020. This share has significantly increased over the past decade, as only 7.56% of the population was above 65 years of age in 2010.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
6.5% |
|
Regional Scope |
|
The market is segmented by application into urinary & fecal incontinence, chronic anal fissure, and others, out of which, the urinary & fecal incontinence segment is anticipated to hold a substantial share in the global bowel stimulators market over the forecast period. Urinary and fecal incontinences are common disorders amongst the elderly, as well as infants and pregnant women. The high prevalence of the disorder is expected to boost the segment growth.
Our in-depth analysis of the global bowel stimulators market includes the following segments:
|
By Product Type |
|
|
By Patient Type |
|
|
By Application |
|
|
By End-User |
|
On the basis of geographical analysis, the global bowel stimulators market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Asia Pacific industry is anticipated to dominate majority revenue share by 2036, driven by increasing healthcare awareness and availability of medical facilities in the developing countries, combined with high geriatric population in countries, such as, Japan and China. As per the data by the World Bank, 11.968% of the population in China was aged 65 years and above in 2020.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the higher incidences of bowel and urinary incontinence, along with availability of efficient treatment methods in the region. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), U.S., published a dataset revealing that amongst people admitted in hospitals and nursing homes, around 18 to 33 patients out of every 100, and between 50 to 70 out of 100 patients have fecal incontinence respectively. Among adults, who are not in hospitals or nursing homes, about 7 and 15 out of 100 individuals have fecal incontinence.
August 24, 2021: Coloplast's SenSura Mio ostomy system has received approval in the U.S. for extended wear, as it reduces leakage while matching or outperforming the wear time of other extended wear products.
October 08, 2020: Laborie Medical Technologies Inc. entered a strategic partnership with Urotronic Inc. to conduct clinical trials for Optilume, a drug-coated balloon (DCB) technology for use in urethral strictures, and benign prostatic hyperplasia (BPH)
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?